Loading data
GRINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 6.82 m USD | 3.77 m USD | 3.23 m USD | 242 k USD | 5.19 m USD |
| Operating profit | -11.98 m USD | -8.24 m USD | -11.39 m USD | -2.24 m USD | -9.26 m USD |
| Income tax expense | 3 k USD | 2 k USD | — | — | — |
| Net income (reported basis) | -11.96 m USD | -8.21 m USD | -13.04 m USD | -3.22 m USD | -9.3 m USD |
| Net income attributable to common shareholders | -11.96 m USD | -10.12 m USD | -13.04 m USD | — | — |
| Basic earnings per share | -121.8 USD/share | -1,545.55 USD/share | -5,018.09 USD/share | -324.31 USD/share | -1.42 USD/share |
| Diluted earnings per share | -121.8 USD/share | -1,545.55 USD/share | -5,018.09 USD/share | -324.31 USD/share | -1.42 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.